Boswellia sacra Flueck. Oleo-gum-resin Nanophytosome: Development, Standardization, and Cholinesterase Inhibitory Potential

AuthorMahnaz Mirimoghaddamen
AuthorMina Saeedien
AuthorMohammad-Reza Delnavazien
AuthorFatemeh Moraffahen
AuthorAida Irajien
AuthorHamid Akbari Javaren
AuthorMahnaz Khanavien
OrcidMahnaz Mirimoghaddam [0009-0006-0568-6533]en
OrcidMina Saeedi [0000-0002-9046-8058]en
OrcidMohammad-Reza Delnavazi [0000-0002-8127-9714]en
OrcidMahnaz Khanavi [0000-0002-4053-6331]en
Issued Date2026-08-31en
AbstractBackground: Alzheimer’s disease (AD) is a progressive neurodegenerative disorder associated with cholinergic dysfunction. The limited efficacy of current acetylcholinesterase inhibitors underscores the need for novel therapeutic approaches. Objectives: This study evaluated the acetylcholinesterase inhibitory activity of Boswellia sacra extracts and their phytosomal formulations. Methods: The methanolic extract of B. sacra was fractionated using potassium hydroxide (KOH) and ethyl acetate to obtain a boswellic acid-enriched fraction, which was further purified by silica gel chromatography to yield two derivatives identified by 1H and 13C nuclear magnetic resonance (NMR) spectroscopy. A phytosomal formulation was prepared using soy lecithin and cholesterol via high-shear homogenization followed by ultrasonication. The optimized nanophytosome was characterized by dynamic light scattering (DLS), Fourier transform infrared (FTIR) spectroscopy, differential scanning calorimetry (DSC), transmission electron microscopy (TEM), and scanning electron microscopy (SEM). Entrapment efficiency, stability, the in vivo release profile, cholinesterase inhibitory activity was assessed using Ellman’s method. Results: Phytochemical analysis yielded 3-acetyl-11-keto-boswellic acid (1) and 11-keto-boswellic acid (2), and compound 1 was used for standardization. The optimized phytosome exhibited a mean particle size of 112 ± 12.28 nm, a polydispersity index (PDI) of 0.23 ± 0.1, a zeta potential of -53 ± 5.87 mV, and an entrapment efficiency of 75.3 ± 1.47%. FTIR and DSC confirmed molecular interactions between lecithin and the extract, whereas TEM and SEM revealed spherical morphology. The optimized phytosomal formulation demonstrated a gradual release profile, reaching 92% after 12 hours, and increased acetylcholinesterase inhibition to 61.0 ± 10.7% (half-maximal inhibitory concentration [IC50], 177.9 ± 26.8 µg/mL) compared with the non-formulated extract. It also showed moderate butyrylcholinesterase inhibition (42 - 48%) and selectivity for acetylcholinesterase inhibition. Conclusions: The optimized phytosomal formulation enhanced in vitro acetylcholinesterase inhibitory activity compared with the non-formulated extract, indicating the potential of this delivery system to improve the biological activity of Boswellia constituents in cell-free enzyme assays. However, these findings are preliminary and limited to in vitro experiments. Further studies are required to assess blood–brain barrier permeability, neuronal uptake, pharmacokinetics, and in vivo therapeutic efficacy.en
DOIhttps://doi.org/10.5812/jjnpp-171846en
URIhttps://brieflands.com/journals/jjnpp/articles/171846en
KeywordBoswellia sacraen
KeywordBoswellic Acidsen
KeywordPhytosomeen
KeywordAcetylcholinesterase Inhibitionen
KeywordNanophytosomeen
KeywordIn Vitro Enzyme Inhibitionen
PublisherBrieflandsen
Title<i>Boswellia sacra</i> Flueck. Oleo-gum-resin Nanophytosome: Development, Standardization, and Cholinesterase Inhibitory Potentialen
TypeResearch Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
jjnpp-21-3-171846-publish-pdf.pdf
Size:
721.93 KB
Format:
Adobe Portable Document Format
Description:
Article/s PDF